BioPlus Acquisition Corp. (BIOS) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 R. Ross Haghighat.
BIOS 을(를) 보유 IPO 날짜 2022-01-28, 에 상장 NASDAQ Global Market, 시가총액 $209.07M.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
